Non Small Cell Lung Cancer Nsclc Clinical Trials

ReadTheTrial indexes 13 studies for Non Small Cell Lung Cancer Nsclc. The most common development stage is Phase 2 (6 trials). Each trial page translates ClinicalTrials.gov eligibility, outcomes, and design into patient-friendly language so you can compare options quickly.

13 clinical trials found for Non Small Cell Lung Cancer Nsclc.

Pipeline by Phase

PhaseTrialsDistribution
Phase 2 6
46%
Phase 3 4
31%
Phase 1 2
15%
N/A 1
8%

Trial Status Breakdown

Trials for Non Small Cell Lung Cancer Nsclc

Phase I/II Study of Neoadjuvant Inhaled Azacytidine With Platinum-Based Chemotherapy and Durvalumab (MEDI4736) - a Combined Epigenetic-Immunotherapy (AZA-AEGEAN) Regimen for Operable Early-Stage Non-Small Cell Lung Cancer (NSCLC)

NCT06694454 · NOT YET RECRUITING · Phase 2

ROSETTA Lung-201: A Randomized, Multicenter, Open-label Phase 3 Study of Pumitamig Monotherapy Compared to Durvalumab in Participants With Unresectable Stage III NSCLC Without Progression After Platinum-based Concurrent Chemoradiation Therapy.

NCT07361497 · RECRUITING · Phase 3

A Phase 2, Open-label, Multicohort Study of Rinatabart Sesutecan (Rina-S) in Participants With Non-Small Cell Lung Cancer

NCT07288177 · RECRUITING · Phase 2

A Phase 1b Study of Gilteritinib in Participants With Locally Advanced or Metastatic NSCLC With ALK Rearrangement After Prior Treatment With an ALK Inhibitor

NCT07140016 · RECRUITING · Phase 1

A Phase 3 Multicenter Double-blind Randomized Study of Taletrectinib Versus Placebo in Patients With ROS1-Fusion Positive Stage IB-IIIA Non-Small Cell Lung Cancer Who Have Undergone Complete Tumor Resection

NCT07154706 · RECRUITING · Phase 3

A Phase 1b/2, Multicenter, Open-label Platform Study of Select Immunotherapy Combinations in Adult Participants With Previously Untreated Advanced Non-small Cell Lung Cancer (NSCLC) With High PD-L1 Expression

NCT06162572 · ACTIVE NOT RECRUITING · Phase 2

A Randomized, Open-label, Phase 3 Study of MK-2870 vs. Platinum Doublets in Participants With EGFR-mutated, Advanced Nonsquamous Non-small Cell Lung Cancer (NSCLC) Who Have Progressed on Prior EGFR Tyrosine Kinase Inhibitors

NCT06305754 · RECRUITING · Phase 3

Phase III Randomized Controlled Trial Comparing Maintenance Systemic Therapy Alone With Systemic Therapy Plus Local Ablative Treatment for Patients With Advanced Stage IV Non-small Cell Lung Cancer

NCT06114108 · RECRUITING · N/A

A Randomized, Open-label, Phase 3 Study of MK-2870 in Combination With Pembrolizumab Compared to Pembrolizumab Monotherapy in the First-line Treatment of Participants With Metastatic Non-small Cell Lung Cancer With PD-L1 TPS Greater Than or Equal to 50% (TroFuse-007)

NCT06170788 · RECRUITING · Phase 3

Phase 1/1b, Multicenter, Open-Label, Dose Escalation and Dose Expansion Study of RMC-6291 Monotherapy in Subjects With Advanced KRASG12C Mutant Solid Tumors

NCT05462717 · ACTIVE NOT RECRUITING · Phase 1

A Cancer Research UK Phase I/IIa Trial of Chimpanzee Adenovirus Oxford 1 (ChAdOx1) and Modified Vaccinia Ankara (MVA) Vaccines Against MAGE-A3 and NY-ESO-1 With Standard of Care Treatment (Chemotherapy and an Immune Checkpoint Inhibitor)

NCT04908111 · SUSPENDED · Phase 2

A Phase II, Multicenter, Two-cohort Study of Oral MET Inhibitor Capmatinib in Chinese Adult Patients With EGFR Wild-type (wt), ALK Rearrangement Negative, MET Exon 14 Skipping Mutations, Advanced Non-small Cell Lung Cancer (NSCLC) Who Are Treatment Naive or Failed One or Two Prior Lines of Systemic Therapy

NCT04677595 · COMPLETED · Phase 2

The Selective Personalized Radio-Immunotherapy for Locally Advanced NSCLC Trial (SPRINT)

NCT03523702 · COMPLETED · Phase 2

Frequently Asked Questions

What clinical trials are available for Non Small Cell Lung Cancer Nsclc?

There are 13 clinical trials listed for Non Small Cell Lung Cancer Nsclc. These span various phases from early safety studies to post-approval monitoring. Browse the trial listings below for details.

How do I find recruiting Non Small Cell Lung Cancer Nsclc trials?

Look for trials with "Recruiting" status in the listings below, or visit our recruiting page to filter by condition. Each trial page includes decoded eligibility criteria to help you determine if you qualify.

What phases are Non Small Cell Lung Cancer Nsclc trials in?

Current Non Small Cell Lung Cancer Nsclc trials are distributed across: Phase 2 (6), Phase 3 (4), Phase 1 (2), N/A (1).

Find More Trials